tk88 bet

Construction on 77 million USD vaccine factory started in Long An province

The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Perspective of the VNVC vaccine and biological products factory in the southern province of Long An. (Photo: baochinhphu.vn)
Perspective of the VNVC vaccine and biological products factory in the southern province of Long An. (Photo: baochinhphu.vn)

Hanoi (VNA) – French President Emmanuel Macron, Vice President Vo Thi Anh Xuan and senior leaders of France and Vietnam pressed the button to start the construction of the VNVC vaccine and biological products factory in the southern province of Long An, realising the cooperation plan to transfer vaccine production technology between the two strategic partners.

The factory covering an area of 26,000 sq.m has an initial investment of 2 trillion VND (77.17 million USD) and a designed capacity of up to 100 million vaccine doses per year. It is expected to be put into operation by the end of 2027, gradually receiving technology transfer from France’s Sanofi to localise the production of important vaccines, new technology vaccines of Sanofi, serving the vaccination needs in Vietnam and joining in the global supply chain.

The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.

chinh-thuc-khoi-cong-nha-may-vaccine-va-sinh-pham-vnvc-baochinhphuvn.jpg
Delegates press the button to start the construction of the VNVC vaccine and biological products factory. (Photo: baochinhphu.vn)

The construction of the factory is an important milestone in realising the comprehensive strategic partnership between France and Vietnam in medicine and biotechnology, which is expected to make practical contributions to the common achievements of the two countries in medicine and health care.

At the same time, it demonstrates the strong determination of Vietnamese enterprises to proactively expand international cooperation, gain access to and master advanced biomedical technologies, and produce high-tech vaccines, thereby contributing to strengthening preventive medicine capacity and ensuring national health security in the face of threats from dangerous infectious diseases and potential future pandemics.

Besides, VNVC is investing in a 1,500sq.m Research and Development Centre (R&D), focusing on advanced vaccine and biological production technologies, particularly mRNA vaccines.

Ngo Chi Dung, Chairman and CEO of VNVC Vaccine JC Company, said the new factory will help reduce costs, ensure a more proactive domestic, witth the potential for export.

Burak Pekmezci, Country Lead at Sanofi Vietnam,♒ said he expects the new factory, built to global standards, will soon provide vaccines, medicines, and disease prevention solutions to Vietnamese people. This will be a breakthrough project, contributing to Sanofi’s mission of improving public health, he added./.

VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

Forum s♉potlights AI and digital innovation𝓀 in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

༒Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|